Howdy. I had a quick look the other day and there wasn't much available.
Number of "active" trials, vs completed / contracted( yet to start )/prospective ... would be difficult to track down, even difficult for CardieX and we are a listed company !
I did see this though from a press release in Dec 2022, which tells me it is a vibrant, growing business. Strong client base & growth.
Our explosive growth has expanded our client base greatly and spans from the top 5 pharma and CROs to small biotech companies. Each looked to Datacubed Health for fast, flexible, accurate eClinical technology to support their studies and guidance from experts who have done this many times before, and we’ve delivered.
Following its initial investment in 2020, Sterling has continued to support Datacubed. Since its inception in 2016, Datacubed has received an aggregate of $45 million in investment funding and has grown revenue by 150% year-over-year since 2018.
Add to My Watchlist
What is My Watchlist?
